The core activity of PreClinical Safety (PCS) Consultants Ltd is to provide consulting and services in the field of drug development, particularly in the preclinical phase. This includes, among others: risk management and assessment, quality assurance and Good Laboratory Practice (GLP), pharmacokinetics and pharmacodynamics, drug development and testing, clinical pharmacology and studies, and regulatory services, including the preparation of regulatory documents such as IBs, INDs, Briefing Books and CTDs. The company offers these services to support customers in decision-making and implementation of drug development projects.